ESTRO 2024 - Abstract Book

S4212

Physics - Intra-fraction motion management and real-time adaptive radiotherapy

ESTRO 2024

Conclusion:

This study comprehensively evaluated the Ethos® adaptive workflow for breast cancer and its potential technical limitations. Although the results demonstrated the high accuracy of AI segmentation and the superiority of adapted plans in terms of target volume coverage, a medical assessment is still required.

Keywords: Ethos, breast cancer, artificial intelligence

985

Mini-Oral

Significantly reduced OAR dose with CBCT guided online adaptive radiotherapy

Matthew Bolt, Rachel Hollingdale, Charlotte Shelley, Chee Goh, Dualta McQuaid, Elizabeth Adams

Royal Surrey County Hospital, Medical Physics, Guildford, United Kingdom